Negligence Suit Over Theft Of Genetic Data Settles For $8.9 Million
ATLANTA — Finding a settlement fund of $8.9 million to be “fair, reasonable, and adequate” to resolve class claims brought against two cancer treatment health care companies that were affected by...To view the full article, register now.
Already a subscriber? Click here to view full article